dog |
LD50 |
oral |
2gm/kg (2000mg/kg) |
? |
"Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 398, 1972. |
hamster |
LD50 |
intraperitoneal |
1050mg/kg (1050mg/kg) |
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
BEHAVIORAL: MUSCLE WEAKNESS
BEHAVIORAL: ATAXIA |
Journal of Pharmacology and Experimental Therapeutics. Vol. 129, Pg. 75, 1960. |
hamster |
LD50 |
oral |
1410mg/kg (1410mg/kg) |
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
BEHAVIORAL: ATAXIA
BEHAVIORAL: MUSCLE WEAKNESS |
Journal of Pharmacology and Experimental Therapeutics. Vol. 129, Pg. 75, 1960. |
mouse |
LD50 |
intraperitoneal |
950mg/kg (950mg/kg) |
? |
Toxicology and Applied Pharmacology. Vol. 2, Pg. 264, 1960. |
mouse |
LD50 |
intravenous |
774mg/kg (774mg/kg) |
? |
Drugs in Japan Vol. 6, Pg. 836, 1982. |
mouse |
LD50 |
oral |
812mg/kg (812mg/kg) |
? |
Drugs in Japan Vol. 6, Pg. 836, 1982. |
mouse |
LD50 |
subcutaneous |
780mg/kg (780mg/kg) |
BEHAVIORAL: ANTICONVULSANT |
Acta Pharmacologica et Toxicologica. Vol. 19, Pg. 247, 1962. |
rabbit |
LD50 |
intravenous |
680mg/kg (680mg/kg) |
SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE
BEHAVIORAL: REGIDITY
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) |
International Journal of Neuropharmacology. Vol. 5, Pg. 305, 1966. |
rat |
LD50 |
intraperitoneal |
815mg/kg (815mg/kg) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) |
Arzneimittel-Forschung. Drug Research. Vol. 17, Pg. 242, 1967. |
rat |
LD50 |
oral |
1320mg/kg (1320mg/kg) |
BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
BEHAVIORAL: MUSCLE WEAKNESS
BEHAVIORAL: ATAXIA |
Journal of Pharmacology and Experimental Therapeutics. Vol. 129, Pg. 75, 1960. |